Literature DB >> 20564016

Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs.

Michelle L Colgrave1, Michael J L Korsinczky, Richard J Clark, Fiona Foley, David J Craik.   

Abstract

Sunflower trypsin inhibitor-1 (SFTI-1) is a 14 amino acid cyclic peptide from sunflower seeds, which possesses exceptionally potent trypsin-inhibitory activity, and has promise as a stable peptide-based drug template. Within its compact structure, SFTI-1 combines a head-to-tail cyclized backbone and a disulfide bond. In this study, we synthesized a range of acyclic and disulfide-deficient analogs of SFTI-1 to investigate enzyme-assisted cyclization of the peptide backbone and proteolytic degradation that occurs as a result of incubation with trypsin. Electrospray and matrix-assisted laser desorption ionization mass spectrometry allowed the characterization of a range of novel degradation products and elucidation of the time-course for cyclization and/or proteolysis. Trypsin displayed the ability to resynthesize the scissile bond(s) and hence cyclize two of the linear permutants, whereas irreversible degradation was observed for another two permutants. An interesting ring contraction mediated by trypsin was observed, supporting a role for protease catalyzed splicing as a way of increasing the combinatorial diversity of cyclic peptides in nature. Disulfide-deficient mutants were degraded within minutes, emphasizing the critical role of the cysteine bridge in maintaining proteolytic stability of SFTI-1. Overall, the study provides additional support for the proposal that naturally occurring cyclic peptides like SFTI-1 are biosynthesized by proteolytic enzymes effectively catalyzing the reverse of their normal reaction to make, rather than break peptide bonds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564016     DOI: 10.1002/bip.21415

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  13 in total

Review 1.  Circular proteins from plants and fungi.

Authors:  Ulf Göransson; Robert Burman; Sunithi Gunasekera; Adam A Strömstedt; K Johan Rosengren
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

2.  Exploitation of the Ornithine Effect Enhances Characterization of Stapled and Cyclic Peptides.

Authors:  Christopher M Crittenden; W Ryan Parker; Zachary B Jenner; Kerry A Bruns; Lucas D Akin; William M McGee; Eugene Ciccimaro; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2016-02-10       Impact factor: 3.109

Review 3.  Ribosomal biosynthesis of the cyclic peptide toxins of Amanita mushrooms.

Authors:  Jonathan D Walton; Heather E Hallen-Adams; Hong Luo
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

4.  Giant macrolactams based on β-sheet peptides.

Authors:  Pin-Nan Cheng; James S Nowick
Journal:  J Org Chem       Date:  2011-04-15       Impact factor: 4.354

Review 5.  Cyclic Opioid Peptides.

Authors:  Michael Remesic; Yeon Sun Lee; Victor J Hruby
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

6.  Microwave-assisted solid-phase synthesis of side-chain to side-chain lactam-bridge cyclic peptides.

Authors:  Srinivasa R Tala; Sathya M Schnell; Carrie Haskell-Luevano
Journal:  Bioorg Med Chem Lett       Date:  2015-10-31       Impact factor: 2.823

7.  Modulation of co-stimulatory signal from CD2-CD58 proteins by a grafted peptide.

Authors:  Pravin Parajuli; Rushikesh Sable; Leeza Shrestha; Achyut Dahal; Ted Gauthier; Veena Taneja; Seetharama Jois
Journal:  Chem Biol Drug Des       Date:  2020-10-02       Impact factor: 2.817

8.  On the Utility of Chemical Strategies to Improve Peptide Gut Stability.

Authors:  Thomas Kremsmayr; Aws Aljnabi; Juan B Blanco-Canosa; Hue N T Tran; Nayara Braga Emidio; Markus Muttenthaler
Journal:  J Med Chem       Date:  2022-04-14       Impact factor: 8.039

Review 9.  Cyclic peptides as therapeutic agents and biochemical tools.

Authors:  Sang Hoon Joo
Journal:  Biomol Ther (Seoul)       Date:  2012-01       Impact factor: 4.634

Review 10.  Miniproteins as phage display-scaffolds for clinical applications.

Authors:  Frederic Zoller; Uwe Haberkorn; Walter Mier
Journal:  Molecules       Date:  2011-03-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.